NEW YORK — Cellink said on Monday that it has signed an agreement to commercialize a range of SeqWell's single-cell RNA sequencing and sample preparation products outside of the US.
Under the terms of the deal, Cellink will sell in ex-US markets SeqWell's PlexWell Single-Cell Rapid Kit for plate-based single-cell RNA sequencing, which is set to launch later this month, as well as its full line of PlexWell next-generation sequencing library preparation kits.
The companies have also agreed to collaborate on new multiplex genomic assay products.